Article
Knocking out alpha-synuclein in melanoma cells downregulates L1CAM and decreases motility
7 Jun 2023
Abstract excerpt
The Parkinson's disease (PD) associated protein, alpha-synuclein (α-syn/SNCA), is highly expressed in aggressive melanomas. The goal of this study was to reveal possible mechanism(s) of α-syn involvement in melanoma pathogenesis. Herein, we asked whether α-syn modulates the expression of the pro-oncogenic adhesion molecules L1CAM and N-cadherin. We used two human melanoma cell lines (SK-MEL-28, SK-MEL-29),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
